Response to highly purified L-asparaginase during therapy of acute leukemia.
D000293:Adolescent; D000328:Adult; D001215:Asparaginase / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood / Q000378:metabolism; D002247:Carbon Isotopes; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D014633:Valine / Q000378:metabolism
D002247:Carbon Isotopes; D001215:Asparaginase; D014633:Valine; D008727:Methotrexate